Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Bactericidal Activity of Delpazolid in Pulmonary Tuberculosis
NCT02836483Phase 2Completed
- Sponsor
- LigaChem Biosciences
- Start
- Dec 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of delpazolid in pulmonary tuberculosis (TB), sponsored by LigaChem Biosciences. Started Dec 2016; status: completed.
02
Drugs
delpazolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT02836483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02836483.